Cargando…

Clinical utility of Gafchromic film in an MRI-guided linear accelerator

BACKGROUND: The purpose of this study is to comprehensively evaluate the suitability of Gafchromic EBT3 and EBT-XD film for dosimetric quality assurance in 0.35 T MR-guided radiotherapy. METHODS: A 0.35 T magnetic field strength was utilized to evaluate magnetic field effects on EBT3 and EBT-XD Gafc...

Descripción completa

Detalles Bibliográficos
Autores principales: Xhaferllari, Ilma, Kim, Joshua P., Liyanage, Ruchira, Liu, Chang, Du, Dongsu, Doemer, Anthony, Chetty, Indrin J., Wen, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236160/
https://www.ncbi.nlm.nih.gov/pubmed/34174932
http://dx.doi.org/10.1186/s13014-021-01844-z
_version_ 1783714481592860672
author Xhaferllari, Ilma
Kim, Joshua P.
Liyanage, Ruchira
Liu, Chang
Du, Dongsu
Doemer, Anthony
Chetty, Indrin J.
Wen, Ning
author_facet Xhaferllari, Ilma
Kim, Joshua P.
Liyanage, Ruchira
Liu, Chang
Du, Dongsu
Doemer, Anthony
Chetty, Indrin J.
Wen, Ning
author_sort Xhaferllari, Ilma
collection PubMed
description BACKGROUND: The purpose of this study is to comprehensively evaluate the suitability of Gafchromic EBT3 and EBT-XD film for dosimetric quality assurance in 0.35 T MR-guided radiotherapy. METHODS: A 0.35 T magnetic field strength was utilized to evaluate magnetic field effects on EBT3 and EBT-XD Gafchromic films by studying the effect of film exposure time within the magnetic field using two timing sequences and film not exposed to MR, the effect of magnetic field exposure on the crystalline structure of the film, and the effect of orientation of the film with respect to the bore within the magnetic field. The orientation of the monomer crystal was qualitatively evaluated using scanning electron microscopy (SEM) compared to unirradiated film. Additionally, dosimetric impact was evaluated through measurements of a series of open field irradiations (0.83 × 0.83-cm(2) to 19.92 × 19.92-cm(2)) and patient specific quality assurance measurements. Open fields were compared to planned dose and an independent dosimeter. Film dosimetry was applied to twenty conventional and twenty stereotactic body radiotherapy (SBRT) patient specific quality assurance cases. RESULTS: No visual changes in crystal orientation were observed in any evaluated SEM images nor were any optical density differences observed between films irradiated inside or outside the magnetic field for both EBT3 and EBT-XD film. At small field sizes, the average difference along dose profiles measured in film compared to the same points measured using an independent dosimeter and to predicted treatment planning system values was 1.23% and 1.56%, respectively. For large field sizes, the average differences were 1.91% and 1.21%, respectively. In open field tests, the average gamma pass rates were 99.8% and 97.2%, for 3%/3 mm and 3%/1 mm, respectively. The median (interquartile range) 3%/3 mm gamma pass rates in conventional QA cases were 98.4% (96.3 to 99.2%), and 3%/1 mm in SBRT QA cases were 95.8% (95.0 to 97.3%). CONCLUSIONS: MR exposure at 0.35 T had negligible effects on EBT3 and EBT-XD Gafchromic film. Dosimetric film results were comparable to planned dose, ion chamber and diode measurements.
format Online
Article
Text
id pubmed-8236160
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82361602021-06-28 Clinical utility of Gafchromic film in an MRI-guided linear accelerator Xhaferllari, Ilma Kim, Joshua P. Liyanage, Ruchira Liu, Chang Du, Dongsu Doemer, Anthony Chetty, Indrin J. Wen, Ning Radiat Oncol Research BACKGROUND: The purpose of this study is to comprehensively evaluate the suitability of Gafchromic EBT3 and EBT-XD film for dosimetric quality assurance in 0.35 T MR-guided radiotherapy. METHODS: A 0.35 T magnetic field strength was utilized to evaluate magnetic field effects on EBT3 and EBT-XD Gafchromic films by studying the effect of film exposure time within the magnetic field using two timing sequences and film not exposed to MR, the effect of magnetic field exposure on the crystalline structure of the film, and the effect of orientation of the film with respect to the bore within the magnetic field. The orientation of the monomer crystal was qualitatively evaluated using scanning electron microscopy (SEM) compared to unirradiated film. Additionally, dosimetric impact was evaluated through measurements of a series of open field irradiations (0.83 × 0.83-cm(2) to 19.92 × 19.92-cm(2)) and patient specific quality assurance measurements. Open fields were compared to planned dose and an independent dosimeter. Film dosimetry was applied to twenty conventional and twenty stereotactic body radiotherapy (SBRT) patient specific quality assurance cases. RESULTS: No visual changes in crystal orientation were observed in any evaluated SEM images nor were any optical density differences observed between films irradiated inside or outside the magnetic field for both EBT3 and EBT-XD film. At small field sizes, the average difference along dose profiles measured in film compared to the same points measured using an independent dosimeter and to predicted treatment planning system values was 1.23% and 1.56%, respectively. For large field sizes, the average differences were 1.91% and 1.21%, respectively. In open field tests, the average gamma pass rates were 99.8% and 97.2%, for 3%/3 mm and 3%/1 mm, respectively. The median (interquartile range) 3%/3 mm gamma pass rates in conventional QA cases were 98.4% (96.3 to 99.2%), and 3%/1 mm in SBRT QA cases were 95.8% (95.0 to 97.3%). CONCLUSIONS: MR exposure at 0.35 T had negligible effects on EBT3 and EBT-XD Gafchromic film. Dosimetric film results were comparable to planned dose, ion chamber and diode measurements. BioMed Central 2021-06-26 /pmc/articles/PMC8236160/ /pubmed/34174932 http://dx.doi.org/10.1186/s13014-021-01844-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xhaferllari, Ilma
Kim, Joshua P.
Liyanage, Ruchira
Liu, Chang
Du, Dongsu
Doemer, Anthony
Chetty, Indrin J.
Wen, Ning
Clinical utility of Gafchromic film in an MRI-guided linear accelerator
title Clinical utility of Gafchromic film in an MRI-guided linear accelerator
title_full Clinical utility of Gafchromic film in an MRI-guided linear accelerator
title_fullStr Clinical utility of Gafchromic film in an MRI-guided linear accelerator
title_full_unstemmed Clinical utility of Gafchromic film in an MRI-guided linear accelerator
title_short Clinical utility of Gafchromic film in an MRI-guided linear accelerator
title_sort clinical utility of gafchromic film in an mri-guided linear accelerator
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236160/
https://www.ncbi.nlm.nih.gov/pubmed/34174932
http://dx.doi.org/10.1186/s13014-021-01844-z
work_keys_str_mv AT xhaferllariilma clinicalutilityofgafchromicfilminanmriguidedlinearaccelerator
AT kimjoshuap clinicalutilityofgafchromicfilminanmriguidedlinearaccelerator
AT liyanageruchira clinicalutilityofgafchromicfilminanmriguidedlinearaccelerator
AT liuchang clinicalutilityofgafchromicfilminanmriguidedlinearaccelerator
AT dudongsu clinicalutilityofgafchromicfilminanmriguidedlinearaccelerator
AT doemeranthony clinicalutilityofgafchromicfilminanmriguidedlinearaccelerator
AT chettyindrinj clinicalutilityofgafchromicfilminanmriguidedlinearaccelerator
AT wenning clinicalutilityofgafchromicfilminanmriguidedlinearaccelerator